Ontology highlight
ABSTRACT: Aim
Approximately one-third of patients with major depressive disorder develop treatment-resistant depression. One-third of patients with treatment-resistant depression demonstrate resistance to ketamine, which is a novel antidepressant effective for this disorder. The objective of this study was to examine the utility of resting-state functional magnetic resonance imaging for the prediction of treatment response to ketamine in treatment-resistant depression.Methods
An exploratory seed-based resting-state functional magnetic resonance imaging analysis was performed to examine baseline resting-state functional connectivity differences between ketamine responders and nonresponders before treatment with multiple intravenous ketamine infusions.Results
Fifteen patients w
SUBMITTER: Nakamura T
PROVIDER: S-EPMC8340826 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature